In addition, the administration of IGF‐I neutralizing antibodies to OVA‐challenged mice reduced the level of respiratory tract inflammation and airway resistance, while increasing the wall thickening of the respiratory tract, suggesting that the inhibition of the IGF‐I signalling pathway might be used as an encouraging approach to treat asthma.30, 31. Here, IGF1 is linked to asthma.